Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Genomic heterogeneity and clinical characterization of SARS-CoV-2 in Oregon

Alexa K Dowdell, Kevin Matlock, Fred L. Robinson, Roshanthi Weerasinghe, Rogan Rattray, Marina Pukay, Melvin Lathara, Anastacia Harlan, Thomas R. Ward, Mary Campbell, Walter Urba, Ganapati Srinivasa, Carlo B. Bifulco, View ORCID ProfileBrian D. Piening
doi: https://doi.org/10.1101/2020.07.30.20160069
Alexa K Dowdell
1Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kevin Matlock
2Omics Data Automation, Beaverton, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fred L. Robinson
1Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roshanthi Weerasinghe
3Health Insights, Providence St. Joseph Health, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rogan Rattray
4Molecular Genomics Laboratory, Providence St. Joseph Health, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marina Pukay
4Molecular Genomics Laboratory, Providence St. Joseph Health, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Melvin Lathara
2Omics Data Automation, Beaverton, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anastacia Harlan
4Molecular Genomics Laboratory, Providence St. Joseph Health, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas R. Ward
4Molecular Genomics Laboratory, Providence St. Joseph Health, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mary Campbell
4Molecular Genomics Laboratory, Providence St. Joseph Health, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Walter Urba
1Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR
4Molecular Genomics Laboratory, Providence St. Joseph Health, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ganapati Srinivasa
2Omics Data Automation, Beaverton, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlo B. Bifulco
1Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR
4Molecular Genomics Laboratory, Providence St. Joseph Health, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brian D. Piening
1Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR
4Molecular Genomics Laboratory, Providence St. Joseph Health, Portland, OR
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Brian D. Piening
  • For correspondence: brian.piening@providence.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

The first reported case of COVID-19 in the State of Oregon occurred in late February 2020, with subsequent outbreaks occurring in the populous Portland metro area but also with significant outbreaks in less-populous and rural areas. Here we report viral sequences from 188 patients across the hospitals and associated clinics in the Providence Health System in the State of Oregon dating back to the early days of the outbreak. We show a significant shift in dominant clade lineages over time in Oregon, with the rapid emergence and dominance of Spike D614G-positive variants. We also highlight significant diversity in SARS-CoV-2 sequences in Oregon, including a large number of rare mutations, indicative that these genomes could be utilized for outbreak tracing. Lastly, we show that SARS-CoV-2 genomic information may offer additional utility in combination with clinical covariates in the prediction of acute disease phenotypes.

Competing Interest Statement

KM, ML and GS are employees of and hold a vested interest in Omics Data Automation, Inc.

Funding Statement

This work was supported by a grant from Providence Foundations of Oregon. Omics Data Automation employees (KM, ML and GS) were supported by a grant from the National Science Foundation under award #1721343.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The Providence St Joseph Health Institutional Review Board reviewed and approved this study (IRB protocol number 2020000127).

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All SARS-CoV-2 sequences generated for this manuscript are publicly available through GISAID.org (under originating laboratory Providence St. Joseph Health Molecular Genomics Laboratory or by author filter for Dowdell et al.). Deidentified clinical data are available upon request.

http://www.gisaid.org

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Back to top
PreviousNext
Posted August 04, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Genomic heterogeneity and clinical characterization of SARS-CoV-2 in Oregon
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Genomic heterogeneity and clinical characterization of SARS-CoV-2 in Oregon
Alexa K Dowdell, Kevin Matlock, Fred L. Robinson, Roshanthi Weerasinghe, Rogan Rattray, Marina Pukay, Melvin Lathara, Anastacia Harlan, Thomas R. Ward, Mary Campbell, Walter Urba, Ganapati Srinivasa, Carlo B. Bifulco, Brian D. Piening
medRxiv 2020.07.30.20160069; doi: https://doi.org/10.1101/2020.07.30.20160069
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Genomic heterogeneity and clinical characterization of SARS-CoV-2 in Oregon
Alexa K Dowdell, Kevin Matlock, Fred L. Robinson, Roshanthi Weerasinghe, Rogan Rattray, Marina Pukay, Melvin Lathara, Anastacia Harlan, Thomas R. Ward, Mary Campbell, Walter Urba, Ganapati Srinivasa, Carlo B. Bifulco, Brian D. Piening
medRxiv 2020.07.30.20160069; doi: https://doi.org/10.1101/2020.07.30.20160069

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (243)
  • Allergy and Immunology (524)
  • Anesthesia (125)
  • Cardiovascular Medicine (1430)
  • Dentistry and Oral Medicine (219)
  • Dermatology (158)
  • Emergency Medicine (292)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (588)
  • Epidemiology (10321)
  • Forensic Medicine (6)
  • Gastroenterology (532)
  • Genetic and Genomic Medicine (2649)
  • Geriatric Medicine (255)
  • Health Economics (499)
  • Health Informatics (1744)
  • Health Policy (791)
  • Health Systems and Quality Improvement (679)
  • Hematology (269)
  • HIV/AIDS (569)
  • Infectious Diseases (except HIV/AIDS) (12112)
  • Intensive Care and Critical Care Medicine (649)
  • Medical Education (274)
  • Medical Ethics (83)
  • Nephrology (291)
  • Neurology (2476)
  • Nursing (145)
  • Nutrition (381)
  • Obstetrics and Gynecology (496)
  • Occupational and Environmental Health (569)
  • Oncology (1330)
  • Ophthalmology (403)
  • Orthopedics (151)
  • Otolaryngology (238)
  • Pain Medicine (172)
  • Palliative Medicine (51)
  • Pathology (343)
  • Pediatrics (784)
  • Pharmacology and Therapeutics (334)
  • Primary Care Research (296)
  • Psychiatry and Clinical Psychology (2415)
  • Public and Global Health (5025)
  • Radiology and Imaging (898)
  • Rehabilitation Medicine and Physical Therapy (532)
  • Respiratory Medicine (686)
  • Rheumatology (309)
  • Sexual and Reproductive Health (257)
  • Sports Medicine (246)
  • Surgery (299)
  • Toxicology (45)
  • Transplantation (141)
  • Urology (108)